Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Renoprotective effect of a novel selective PPAR╬▒ modulator K-877 in db/db mice: A role of diacylglycerol-protein kinase C-NAD(P)H oxidase pathway.

Maki T, Maeda Y, Sonoda N, Makimura H, Kimura S, Maeno S, Takayanagi R, Inoguchi T.

Metabolism. 2017 Jun;71:33-45. doi: 10.1016/j.metabol.2017.02.013. Epub 2017 Mar 3.

PMID:
28521876
2.

Associations between plasma branched-chain amino acids, ╬▓-aminoisobutyric acid and body composition.

Rietman A, Stanley TL, Clish C, Mootha V, Mensink M, Grinspoon SK, Makimura H.

J Nutr Sci. 2016 Feb 3;5:e6. doi: 10.1017/jns.2015.37. eCollection 2016.

3.

FNDC5 relates to skeletal muscle IGF-I and mitochondrial function and gene expression in obese men with reduced growth hormone.

Srinivasa S, Suresh C, Mottla J, Hamarneh SR, Irazoqui JE, Frontera W, Torriani M, Stanley T, Makimura H.

Growth Horm IGF Res. 2016 Feb;26:36-41. doi: 10.1016/j.ghir.2015.12.008. Epub 2015 Dec 17.

4.

Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.

Makimura H, Stanley TL, Suresh C, De Sousa-Coelho AL, Frontera WR, Syu S, Braun LR, Looby SE, Feldpausch MN, Torriani M, Lee H, Patti ME, Grinspoon SK.

J Clin Endocrinol Metab. 2016 Mar;101(3):1123-33. doi: 10.1210/jc.2015-3696. Epub 2015 Dec 21.

5.

GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.

Inoue T, Inoguchi T, Sonoda N, Hendarto H, Makimura H, Sasaki S, Yokomizo H, Fujimura Y, Miura D, Takayanagi R.

Atherosclerosis. 2015 May;240(1):250-9. doi: 10.1016/j.atherosclerosis.2015.03.026. Epub 2015 Mar 18.

PMID:
25818251
6.

Relationship between serum IGF-1 and skeletal muscle IGF-1 mRNA expression to phosphocreatine recovery after exercise in obese men with reduced GH.

Hamarneh SR, Murphy CA, Shih CW, Frontera W, Torriani M, Irazoqui JE, Makimura H.

J Clin Endocrinol Metab. 2015 Feb;100(2):617-25. doi: 10.1210/jc.2014-2711. Epub 2014 Nov 6.

7.

Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity.

Stanley TL, Feldpausch MN, Murphy CA, Grinspoon SK, Makimura H.

Growth Horm IGF Res. 2014 Feb;24(1):10-5. doi: 10.1016/j.ghir.2013.11.001. Epub 2013 Nov 15.

8.

The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.

Makimura H, Murphy CA, Feldpausch MN, Grinspoon SK.

J Clin Endocrinol Metab. 2014 Jan;99(1):338-43. doi: 10.1210/jc.2013-3436. Epub 2013 Dec 20.

9.

Central diabetes insipidus: a previously unreported side effect of temozolomide.

Faje AT, Nachtigall L, Wexler D, Miller KK, Klibanski A, Makimura H.

J Clin Endocrinol Metab. 2013 Oct;98(10):3926-31. doi: 10.1210/jc.2013-2435. Epub 2013 Aug 8.

10.

Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.

Makimura H, Feldpausch MN, Rope AM, Hemphill LC, Torriani M, Lee H, Grinspoon SK.

J Clin Endocrinol Metab. 2012 Dec;97(12):4769-79. doi: 10.1210/jc.2012-2794. Epub 2012 Sep 26.

11.

The association of macro- and micronutrient intake with growth hormone secretion.

Denny-Brown S, Stanley TL, Grinspoon SK, Makimura H.

Growth Horm IGF Res. 2012 Jun-Aug;22(3-4):102-7. doi: 10.1016/j.ghir.2012.03.001. Epub 2012 Apr 1.

12.

Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.

Zanni MV, Burdo TH, Makimura H, Williams KC, Grinspoon SK.

Clin Endocrinol (Oxf). 2012 Sep;77(3):385-90. doi: 10.1111/j.1365-2265.2011.04284.x.

13.

Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size.

Makimura H, Feldpausch MN, Stanley TL, Sun N, Grinspoon SK.

Clin Endocrinol (Oxf). 2012 Feb;76(2):220-7. doi: 10.1111/j.1365-2265.2011.04195.x.

14.

Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor.

Makimura H, Stanley TL, Chen CY, Branch KL, Grinspoon SK.

Growth Horm IGF Res. 2011 Jun;21(3):155-9. doi: 10.1016/j.ghir.2011.03.009. Epub 2011 Apr 30.

15.

Obesity: Cure obesity: sleep more, eat out less and turn down the heat?

Makimura H.

Nat Rev Endocrinol. 2011 Jun;7(6):318-9. doi: 10.1038/nrendo.2011.55. Epub 2011 Mar 29. No abstract available.

PMID:
21448142
16.

Increased skeletal muscle phosphocreatine recovery after sub-maximal exercise is associated with increased carotid intima-media thickness.

Makimura H, Stanley TL, Sun N, Connelly JM, Hemphill LC, Hrovat MI, Systrom DM, Grinspoon SK.

Atherosclerosis. 2011 Mar;215(1):214-7. doi: 10.1016/j.atherosclerosis.2010.11.037. Epub 2010 Dec 5.

17.

The association of growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men.

Makimura H, Stanley TL, Sun N, Hrovat MI, Systrom DM, Grinspoon SK.

J Clin Endocrinol Metab. 2011 Mar;96(3):817-23. doi: 10.1210/jc.2010-2264. Epub 2010 Dec 22.

18.

TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.

Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H, Khor VK, Ahima RS, Grinspoon SK.

J Clin Endocrinol Metab. 2011 Jan;96(1):E146-50. doi: 10.1210/jc.2010-1170. Epub 2010 Nov 3.

19.

Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.

Stanley TL, Chen CY, Branch KL, Makimura H, Grinspoon SK.

J Clin Endocrinol Metab. 2011 Jan;96(1):150-8. doi: 10.1210/jc.2010-1587. Epub 2010 Oct 13.

20.

The relationship between reduced testosterone, stimulated growth hormone secretion and increased carotid intima-media thickness in obese men.

Makimura H, Stanley TL, Sun N, Connelly JM, Hemphill LC, Grinspoon SK.

Clin Endocrinol (Oxf). 2010 Nov;73(5):622-9. doi: 10.1111/j.1365-2265.2010.03859.x.

Supplemental Content

Loading ...
Support Center